Farmakokinetická interakce metamfetaminu a fluoxetinu na úrovni CYP450 2D1 v preklinickém experimentu

DOSTÁLEK, Miroslav and Jiří SLÍVA. Farmakokinetická interakce metamfetaminu a fluoxetinu na úrovni CYP450 2D1 v preklinickém experimentu (Pharmacokinetics interaction of methamphetamine and fluoxetine on metabolic activity of CYP2D1 in preclinical experiment). In 46. Studentská vědecká konference. Brno: Lékařská fakulta MU v Brně, 2002, p. 2-3.

Basic information

Original name

Farmakokinetická interakce metamfetaminu a fluoxetinu na úrovni CYP450 2D1 v preklinickém experimentu

Name in Czech

Farmakokinetická interakce metamfetaminu a fluoxetinu na úrovni CYP450 2D1 v preklinickém experimentu

Authors

DOSTÁLEK, Miroslav (203 Czech Republic, guarantor) and Jiří SLÍVA (203 Czech Republic)

Edition

Brno, 46. Studentská vědecká konference, p. 2-3, 2 pp. 2002

Publisher

Lékařská fakulta MU v Brně

---

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/02:00006929

Organization unit

Faculty of Medicine

Keywords in English

izolated perfused liver;methamphetamine; fluoxetine; CYP2D1

Tags

CYP2D1, fluoxetine, izolated perfused liver, methamphetamine

---

Abstract

V originále

The aim of the present study was to investigate the influence of fluoxetine on the metabolic activity of CYP2D1/2 and CYP3A1/2 in the isolated perfused liver of rats pretreated by methamphetamine.

In Czech

The aim of the present study was to investigate the influence of fluoxetine on the metabolic activity of CYP2D1/2 and CYP3A1/2 in the isolated perfused liver of rats pretreated by methamphetamine.